Wellington Management Funds (Luxembourg) III SICAV - Wellington Emerging Markets Health Care Equity Fund USD UD AccU

Reference Data

ISIN LU2404423373
Valor Number 115550442
Bloomberg Global ID WEHUDAD LX
Fund Name Wellington Management Funds (Luxembourg) III SICAV - Wellington Emerging Markets Health Care Equity Fund USD UD AccU
Fund Provider Wellington Management Company LLP Web: https://www.wellingtonfunds.com
Fund Provider Wellington Management Company LLP
Representative in Switzerland BNP Paribas, Paris, Zurich Branch
Zürich
Distributor(s) Wellington Global Administrator Ltd.
Hamilton
Asset Class Equities
EFC Category Equity Health Care
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** The investment objective of the Fund is to seek long-term total returns in excess of the S&P BMI Emerging Markets Health Care Index (the "Index"), primarily investing in health care companies that are located in and/or conduct substantial business in emerging market countries, inclusive of frontier market countries (as defined by MSCI).
Peculiarities

Fund Prices

Current Price * 7.86 USD 04.11.2024
Previous Price * 7.74 USD 01.11.2024
52 Week High * 8.27 USD 04.10.2024
52 Week Low * 6.65 USD 18.04.2024
NAV * 7.86 USD 04.11.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 879,117
Unit/Share Assets *** 7,787
Trading Information SIX

Performance

YTD Performance +0.58% 29.12.2023
04.11.2024
YTD Performance (in CHF) +3.71% 29.12.2023
04.11.2024
1 month -5.00% 04.10.2024
04.11.2024
3 months +11.62% 05.08.2024
04.11.2024
6 months +8.56% 06.05.2024
04.11.2024
1 year +0.87% 06.11.2023
04.11.2024
2 years -2.60% 04.11.2022
04.11.2024
3 years -21.42% 16.12.2021
04.11.2024
5 years - -

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Apollo Hospitals Enterprise Ltd 6.26%
Innovent Biologics Inc 4.96%
IHH Healthcare Bhd 4.44%
Torrent Pharmaceuticals Ltd 4.40%
Jiangsu Hengrui Pharmaceuticals Co Ltd Class A 4.21%
Cipla Ltd 3.97%
Hapvida Participacoes Investimento SA Ordinary Shares 3.59%
Fortis Healthcare Ltd 3.58%
Genomma Lab Internacional SAB de CV Class B 3.42%
Sino Biopharmaceutical Ltd 3.25%
Last data update 30.09.2024

Cost / Risk

TER 1.85%
TER date 15.09.2023
Performance Fee ***
PTR
Max. Management Fee *** 1.10%
Ongoing Charges *** 1.85%
SRRI ***
SRRI date *** 31.10.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)